Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Adviser Urges More Attention to Gender-Specific Drugs

This article was originally published in PharmAsia News

Executive Summary

An adviser at India's National Institute of Immunology says the country should place more emphasis on the differences between drugs for males and those for females. N.K. Ganguly said the country currently produces drugs focused on the needs of men while ignoring the needs of women even though the needs of each are quite different. India has developed about 30 life-saving drugs in the past few years, Ganguly said, but many are neither compatible nor affordable for Indian women. He urged drug makers to consider the changing needs of the country. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts